The demand for Anti-Diabetes Drugs in Timor-Leste has been steadily increasing over the past few years.
Customer preferences: The majority of the population in Timor-Leste suffers from Type 2 Diabetes, which is caused by a combination of genetic and lifestyle factors. As a result, there is a high demand for oral medications that help control blood sugar levels. Patients prefer medications that are easy to take and have minimal side effects.
Trends in the market: The market for Anti-Diabetes Drugs in Timor-Leste is dominated by multinational pharmaceutical companies that offer a wide range of medications. Metformin is the most commonly prescribed medication due to its affordability and effectiveness in controlling blood sugar levels. However, there has been a recent trend towards newer medications such as DPP-4 inhibitors and GLP-1 receptor agonists, which have fewer side effects and provide better blood sugar control.
Local special circumstances: Timor-Leste is a small, developing country with a relatively low GDP per capita. As a result, many patients cannot afford expensive medications and rely on government subsidies or generic versions of drugs. The lack of healthcare infrastructure and trained healthcare professionals is also a challenge for patients seeking treatment.
Underlying macroeconomic factors: The growing prevalence of Type 2 Diabetes in Timor-Leste is linked to changing lifestyles, including increased consumption of processed foods and decreased physical activity. The government has implemented initiatives to promote healthy eating and exercise, but progress has been slow due to limited resources. The country's dependence on oil revenues has also affected healthcare spending, with budget cuts affecting the availability of medications and healthcare services.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
